Study Information

Title: A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures External
Status: Recruiting participants
Conditions: Tuberous Sclerosis Complex-associated Refractory Seizures
Interventions: Drug: RAD001; Drug: Placebo
Institutions: Children's Hospital Boston
Health Topics: Epilepsy

Contact Information


Children's Hospital Boston SC
Boston, MA 02115
Kira A. Dies
617-919-3009
Kira.dies@childrens.harvard.edu